Oral glucocorticoids have no impact on the efficacy or safety profile of rituximab in rheumatoid arthitis (RA) patients with inadequate response to TNF inhibitors (REFLEX study).

Ruderman, E. M.; Durez, Patrick; Burmester, G. R.; Loveless, J.; Kvien, T. K.; Jackson, C.; Burke, L.; Cravets, M.; White, A. M.

Oral glucocorticoids have no impact on the efficacy or safety profile of rituximab in rheumatoid arthitis (RA) patients with inadequate response to TNF inhibitors (REFLEX study).

Ruderman, E. M.

;

Durez, Patrick

;

Burmester, G. R.

;

Loveless, J.

;

White, A. M.

;et.al.

(2006) 70th Annual Scientific Meeting of the American-College-of-Rheumatology/41st Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals — Location: Washington (Dc) (10.November.2006)

Files

No attached file found for this publication.

Details

Authors

Ruderman, E. M.
Author
Durez, PatrickUCLouvain
Author
Burmester, G. R.
Author
Loveless, J.
Author
White, A. M.
Author

Affiliations

Citations

APA
Chicago
FWB

Ruderman, E. M., Durez, P., Burmester, G. R., Loveless, J., Kvien, T. K., Jackson, C., Burke, L., Cravets, M., & White, A. M. (2006). Oral glucocorticoids have no impact on the efficacy or safety profile of rituximab in rheumatoid arthitis (RA) patients with inadequate response to TNF inhibitors (REFLEX study). Arthritis & Rheumatism, 54(9), S226-S227. https://hdl.handle.net/2078.5/63712 (Original work published 2006)